home > novo nordisk official site >

Novo Nordisk Counting on New Diabetes Drug Tresiba to Dominate

by Odelia Benson    
4656784 views

Shares of Novo Nordisk popped 5% last week after the U.S. Food and Drug Administration (FDA) approved the application for its long-acting insulin drug Tresiba ...

Comments on the Novo Nordisk Counting on New Diabetes Drug Tresiba to Dominate